{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:57:04Z","timestamp":1765886224967,"version":"3.41.2"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.567783","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T05:49:16Z","timestamp":1602654556000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Expansion of Polymorphonuclear Myeloid-Derived Suppressor Cells in Patients With Gout"],"prefix":"10.3389","volume":"11","author":[{"given":"Limei","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sitao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donglin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.26442\/terarkh201890588-92","article-title":"Gout. New opportunities of diagnosis and treatment","volume":"90","author":"Yakupova","year":"2018","journal-title":"Terapevticheskii Arkhiv"},{"key":"B2","doi-asserted-by":"publisher","first-page":"i20","DOI":"10.1093\/rheumatology\/kex442","article-title":"Treat to target in gout","volume":"57","author":"Perez-Ruiz","year":"2018","journal-title":"Rheumatology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/icb.2009.91","article-title":"The natural killer cell: a further innate mediator of gouty inflammation?","volume":"88","author":"Empson","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5647074","DOI":"10.1155\/2019\/5647074","article-title":"Inhibition of triggering receptor expressed on myeloid cell-1 alleviates acute gouty inflammation","volume":"2019","author":"He","year":"2019","journal-title":"Mediat Inflamm"},{"key":"B6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrrheum.2012.143","article-title":"Uric acid as a danger signal in gout and its comorbidities","volume":"9","author":"Rock","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"B7","first-page":"90","article-title":"The immunological basis in the pathogenesis of gout","volume":"14","author":"Chen","year":"2017","journal-title":"Iran J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature."},{"key":"B9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1074\/jbc.M110.139048","article-title":"Sodium overload and water influx activate the NALP3 inflammasome","volume":"286","author":"Schorn","year":"2011","journal-title":"J Biol Chem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/1568010054022114","article-title":"Neutrophil-derived cytokines: potential therapeutic targets in inflammation","volume":"4","author":"Kasama","year":"2005","journal-title":"Curr Drugs Targets Inflamm Allergy"},{"key":"B11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.intimp.2011.01.026","article-title":"MDSC in autoimmunity","volume":"11","author":"Cripps","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.humimm.2016.05.024","article-title":"Myeloid derived suppressor cells and autoimmunity","volume":"77","author":"Boros","year":"2016","journal-title":"Human Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00262-018-2264-3","article-title":"Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation","volume":"68","author":"Amodio","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jim.2012.04.004","article-title":"Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples","volume":"381","author":"Kotsakis","year":"2012","journal-title":"J Immunol Methods"},{"key":"B16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1365-2567.2012.03566.x","article-title":"S100A9 a new marker for monocytic human myeloid-derived suppressor cells","volume":"136","author":"Zhao","year":"2012","journal-title":"Immunology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1158\/2326-6066.CIR-18-0578","article-title":"Mediators of inflammation-driven expansion, trafficking, and function of tumor-infiltrating MDSCs","volume":"7","author":"Tannenbaum","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2051-1426-1-10","article-title":"Myeloid derived suppressor cells\u2013a new therapeutic target in the treatment of cancer","volume":"1","author":"Wesolowski","year":"2013","journal-title":"J Immunother Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell\u2013suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4049\/jimmunol.1203535","article-title":"Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis","volume":"191","author":"Fujii","year":"2013","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/03009742.2012.716450","article-title":"Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis","volume":"42","author":"Jiao","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.semarthrit.2015.07.003","article-title":"The potential therapeutic role of myeloid-derived suppressor cells in autoimmune arthritis","volume":"45","author":"Wang","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"B23","doi-asserted-by":"publisher","first-page":"331ra340","DOI":"10.1126\/scitranslmed.aae0482","article-title":"Arginase-1\u2013dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus","volume":"8","author":"Wu","year":"2016","journal-title":"Sci Transl Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5474828","DOI":"10.1155\/2018\/5474828","article-title":"The expansion of myeloid-derived suppressor cells is associated with joint inflammation in rheumatic patients with arthritis","volume":"2018","author":"Zhu","year":"2018","journal-title":"BioMed Res Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheumat."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1038\/onc.2016.448","article-title":"IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer","volume":"36","author":"Yang","year":"2017","journal-title":"Oncogene"},{"key":"B27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/eji.201545798","article-title":"Transmembrane TNF-\u03b1 is sufficient for articular inflammation and hypernociception in a mouse model of gout","volume":"46","author":"Amaral","year":"2016","journal-title":"Eur J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.1073\/pnas.1818164116","article-title":"Transcriptional factor ATF3 protects against colitis by regulating follicular helper T cells in Peyer's patches","volume":"116","author":"Cao","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"aaf8943","DOI":"10.1126\/sciimmunol.aaf8943","article-title":"Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients","volume":"1","author":"Condamine","year":"2016","journal-title":"Sci Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Comm"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.kint.2016.12.015","article-title":"Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications","volume":"91","author":"Xing","year":"2017","journal-title":"Kidney Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/eji.201444799","article-title":"Functional characterization of myeloid-derived suppressor cell subpopulations during the development of experimental arthritis","volume":"45","author":"Wang","year":"2015","journal-title":"Eur J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/annrheumdis-2014-205508","article-title":"Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis","volume":"75","author":"Guo","year":"2016","journal-title":"Ann Rheumat Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"8965925","DOI":"10.1155\/2020\/8965925","article-title":"Patient characteristics related to blood loss in high tibial osteotomy in novel multiple linear regression analysis","volume":"2020","author":"Zhu","year":"2020","journal-title":"BioMed Res Int"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.3389\/fimmu.2019.02183","article-title":"C-Reactive protein promotes the expansion of myeloid derived cells with suppressor functions","volume":"10","author":"Jimenez","year":"2019","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"F1358","DOI":"10.1152\/ajprenal.00476.2012","article-title":"C-reactive protein exacerbates renal ischemia-reperfusion injury","volume":"304","author":"Pegues","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1172\/JCI115142","article-title":"Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution","volume":"87","author":"di Giovine","year":"1991","journal-title":"J Clin Investig"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3346\/jkms.2017.32.12.1967","article-title":"Elderly patients exhibit stronger inflammatory responses during gout attacks","volume":"32","author":"Lee","year":"2017","journal-title":"J Korean Med Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-63318-8","article-title":"C-reactive protein (CRP) recognizes uric acid crystals and recruits proteases C1 and MASP1","volume":"10","author":"Alberts","year":"2020","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1042\/CS20160311","article-title":"Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs","volume":"130","author":"Ji","year":"2016","journal-title":"Clin Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.567783\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T05:49:19Z","timestamp":1602654559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.567783\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2020.567783"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.567783","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"article-number":"567783"}}